William Blair & Company’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,130
Closed -$203K 1854
2023
Q4
$203K Hold
3,130
﹤0.01% 1395
2023
Q3
$205K Buy
+3,130
New +$197K ﹤0.01% 1381
2022
Q4
Sell
-3,130
Closed -$227K 1880
2022
Q3
$227K Hold
3,130
﹤0.01% 1341
2022
Q2
$213K Sell
3,130
-126
-4% -$9.05K ﹤0.01% 1394
2022
Q1
$295K Sell
3,256
-261
-7% -$21.4K ﹤0.01% 1371
2021
Q4
$321K Buy
3,517
+387
+12% +$33.2K ﹤0.01% 1396
2021
Q3
$254K Hold
3,130
﹤0.01% 1398
2021
Q2
$292K Buy
+3,130
New +$303K ﹤0.01% 1355

Other funds holding NARI

William Blair & Company's NARI Position: Q1 2024 in Review

William Blair & Company sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2024, closing a stake of 3,130 shares — an estimated $203K sold.

William Blair & Company first reported a position in NARI in Q2 2021 and held it in 8 quarters. The position peaked at $321K in Q4 2021. 231 funds tracked by Wall St. Rank hold NARI as of Q1 2024.

  • William Blair & Company reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • William Blair & Company sold 3,130 Inari Medical, Inc. Common Stock shares in Q1 2024, an estimated $203K.
  • William Blair & Company first reported a position in Inari Medical, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • William Blair & Company's Inari Medical, Inc. Common Stock position peaked at $321K in Q4 2021.
  • 231 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2024.

Based on William Blair & Company's 13F filing for Q1 2024, filed 9 May 2024.